南京科佰生物科技有限公司

主營(yíng)產(chǎn)品: atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫(kù)購(gòu)買

11

聯(lián)系電話

18066071954

您現(xiàn)在的位置: 南京科佰生物科技有限公司>>藥靶細(xì)胞株>>kinase激酶細(xì)胞株>> CBP73249AXL (Gas6 Dependent)/BaF3

公司信息

聯(lián)人:
蔣經(jīng)理
話:
4008750250
機(jī):
18066071954
真:
址:
南京市棲霞區(qū)緯地路9號(hào)
編:
210000
個(gè)化:
www.co-bioer.com
網(wǎng)址:
www.cobioer.com/
鋪:
http://true-witness.com/st281842/
給他留言
CBP73249AXL (Gas6 Dependent)/BaF3
AXL (Gas6 Dependent)/BaF3
參考價(jià) 面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)
  • 型號(hào) CBP73249
  • 品牌 cobioer/科佰生物
  • 廠商性質(zhì) 代理商
  • 所在地 南京市

更新時(shí)間:2022-08-01 15:50:50瀏覽次數(shù):729

聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!

【簡(jiǎn)單介紹】
供貨周期 現(xiàn)貨 貨號(hào) CBP73249
應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
AXL (Gas6 Dependent)/BaF3,母細(xì)胞:BaF3,AXL (TYRO7) 是一種受體酪氨酸激酶,在各種形式的癌癥中過(guò)度表達(dá),包括乳腺癌、前列腺癌、結(jié)腸直腸癌和非小細(xì)胞癌。 AXL 過(guò)表達(dá)已被證明可促進(jìn)腫瘤進(jìn)展和轉(zhuǎn)移并降低抗腫瘤免疫反應(yīng),使 AXL 成為抗癌治療的有吸引力的候選者。
【詳細(xì)說(shuō)明】


CBP73249
I. Introduction

Cell Line Name:

AXL (Gas6 Dependent)/BaF3

Host Cell:

BA/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10% FBS+2 ug/ml puromycin

Mycoplasma Status:

Negative


II.Background
AXL (TYRO7) is a receptor tyrosine kinase that is overexpressed in various forms of cancer, including breast, prostate, colorectal, and non-small cell cancers. AXL overexpression has been shown to encourage tumor progression and metastasis and to decrease the anti-tumor immune response, making AXL an attractive candidate for anticancer therapies.

III. Representative Data

1. Anti-proliferation assay

CBP73249 fig1.png

CBP73249 fig2.jpg


Figure 1. Anti-proliferation assay of three reference compounds on the AXL (Gas6 Dependent)/BaF3 Stable Cell Line.





產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 二維碼 在線交流

掃一掃訪問(wèn)手機(jī)商鋪

對(duì)比框

在線留言